204 related articles for article (PubMed ID: 33049493)
1. The dipeptidyl peptidase (DPP)-4 inhibitor trelagliptin inhibits IL-1β-induced endothelial inflammation and monocytes attachment.
Meng J; Zhang W; Wang C; Xiong S; Wang Q; Li H; Liu G; Hao Z
Int Immunopharmacol; 2020 Dec; 89(Pt B):106996. PubMed ID: 33049493
[TBL] [Abstract][Full Text] [Related]
2. META060 attenuates TNF-α-activated inflammation, endothelial-monocyte interactions, and matrix metalloproteinase-9 expression, and inhibits NF-κB and AP-1 in THP-1 monocytes.
Desai A; Darland G; Bland JS; Tripp ML; Konda VR
Atherosclerosis; 2012 Jul; 223(1):130-6. PubMed ID: 22658256
[TBL] [Abstract][Full Text] [Related]
3. The dipeptidyl peptidase-IV inhibitor inhibits the expression of vascular adhesion molecules and inflammatory cytokines in HUVECs via Akt- and AMPK-dependent mechanisms.
Hwang HJ; Chung HS; Jung TW; Ryu JY; Hong HC; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH; Yoo HJ
Mol Cell Endocrinol; 2015 Apr; 405():25-34. PubMed ID: 25661535
[TBL] [Abstract][Full Text] [Related]
4. The DPP-4 inhibitor saxagliptin ameliorates ox-LDL-induced endothelial dysfunction by regulating AP-1 and NF-κB.
Ma S; Bai Z; Wu H; Wang W
Eur J Pharmacol; 2019 May; 851():186-193. PubMed ID: 30639312
[TBL] [Abstract][Full Text] [Related]
5. Histamine H1 type receptor antagonist loratadine ameliorates oxidized LDL induced endothelial dysfunction.
Zhou Y; Gao C; Wang H; Liu L; Huang Z; Fa X
Biomed Pharmacother; 2018 Oct; 106():1448-1453. PubMed ID: 30119218
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl-peptidase-4 inhibitor, alogliptin, attenuates arterial inflammation and neointimal formation after injury in low-density lipoprotein (LDL) receptor-deficient mice.
Akita K; Isoda K; Shimada K; Daida H
J Am Heart Assoc; 2015 Mar; 4(3):e001469. PubMed ID: 25770025
[TBL] [Abstract][Full Text] [Related]
7. Tofacitinib inhibits ox-LDL-induced adhesion of THP-1 monocytes to endothelial cells.
Yang X; Wan M; Cheng Z; Wang Z; Wu Q
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2775-2782. PubMed ID: 31284768
[TBL] [Abstract][Full Text] [Related]
8. Trelagliptin ameliorates IL-1β-impaired chondrocyte function via the AMPK/SOX-9 pathway.
Liu J; Zuo Q; Li Z; Chen J; Liu F
Mol Immunol; 2021 Dec; 140():70-76. PubMed ID: 34666245
[TBL] [Abstract][Full Text] [Related]
9. Netrin-1 prevents the attachment of monocytes to endothelial cells via an anti-inflammatory effect.
Lin Z; Jin J; Bai W; Li J; Shan X
Mol Immunol; 2018 Nov; 103():166-172. PubMed ID: 30290313
[TBL] [Abstract][Full Text] [Related]
10. Juglanin suppresses oscillatory shear stress-induced endothelial dysfunction: An implication in atherosclerosis.
Zhao J; Quan X; Xie Z; Zhang L; Ding Z
Int Immunopharmacol; 2020 Dec; 89(Pt B):107048. PubMed ID: 33049495
[TBL] [Abstract][Full Text] [Related]
11. Uric acid promotes chemokine and adhesion molecule production in vascular endothelium via nuclear factor-kappa B signaling.
Liang WY; Zhu XY; Zhang JW; Feng XR; Wang YC; Liu ML
Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):187-94. PubMed ID: 25315669
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein M and sphingosine-1-phosphate complex alleviates TNF-α-induced endothelial cell injury and inflammation through PI3K/AKT signaling pathway.
Liu Y; Tie L
BMC Cardiovasc Disord; 2019 Dec; 19(1):279. PubMed ID: 31791242
[TBL] [Abstract][Full Text] [Related]
13. Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism.
Grimshaw CE; Jennings A; Kamran R; Ueno H; Nishigaki N; Kosaka T; Tani A; Sano H; Kinugawa Y; Koumura E; Shi L; Takeuchi K
PLoS One; 2016; 11(6):e0157509. PubMed ID: 27328054
[TBL] [Abstract][Full Text] [Related]
14. Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice.
Salim HM; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
Vascul Pharmacol; 2017 Sep; 96-98():19-25. PubMed ID: 28347868
[TBL] [Abstract][Full Text] [Related]
15. Multiple anti-inflammatory and anti-atherosclerotic properties of red wine polyphenolic extracts: differential role of hydroxycinnamic acids, flavonols and stilbenes on endothelial inflammatory gene expression.
Calabriso N; Scoditti E; Massaro M; Pellegrino M; Storelli C; Ingrosso I; Giovinazzo G; Carluccio MA
Eur J Nutr; 2016 Mar; 55(2):477-489. PubMed ID: 25724173
[TBL] [Abstract][Full Text] [Related]
16. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
[TBL] [Abstract][Full Text] [Related]
17. Chrysin Suppresses Vascular Endothelial Inflammation via Inhibiting the NF-κB Signaling Pathway.
Zhao S; Liang M; Wang Y; Hu J; Zhong Y; Li J; Huang K; Li Y
J Cardiovasc Pharmacol Ther; 2019 May; 24(3):278-287. PubMed ID: 30497287
[TBL] [Abstract][Full Text] [Related]
18. Docosahexaenoic acid and eicosapentaenoic acid suppress adhesion molecule expression in human aortic endothelial cells via differential mechanisms.
Huang CY; Sheu WH; Chiang AN
Mol Nutr Food Res; 2015 Apr; 59(4):751-62. PubMed ID: 25631736
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 receptor agonist dulaglutide prevents ox-LDL-induced adhesion of monocytes to human endothelial cells: An implication in the treatment of atherosclerosis.
Chang W; Zhu F; Zheng H; Zhou Z; Miao P; Zhao L; Mao Z
Mol Immunol; 2019 Dec; 116():73-79. PubMed ID: 31630078
[TBL] [Abstract][Full Text] [Related]
20. Glycolipids from spinach suppress LPS-induced vascular inflammation through eNOS and NK-κB signaling.
Ishii M; Nakahara T; Araho D; Murakami J; Nishimura M
Biomed Pharmacother; 2017 Jul; 91():111-120. PubMed ID: 28448865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]